Skip to main content

APOE genotype affects outcome in a murine model of sepsis: implications for a new treatment strategy.

Publication ,  Journal Article
Wang, H; Christensen, DJ; Vitek, MP; Sullivan, PM; Laskowitz, DT
Published in: Anaesth Intensive Care
January 2009

In this study, we assessed whether apolipoprotein E (APOE) polymorphism affects inflammatory responses and mortality in the caecal ligation and puncture model of peritonitis. In addition, we determined the effects of APOE mimetic peptide administration in this sepsis model. Differences in survival between targeted replacement mice expressing the human APOE3 allele (APOE3TR) and the APOE4 allele (APOE4TR) mice were assessed. In a separate series of experiments, COG1410, an apoE-mimetic peptide, was administered intravenously at 12-hour intervals for 72 hours and compared to vehicle-treated control animals. End-points included mortality and serum levels of interleukin-1beta, interleukin-6, interleukin-12 and tumour necrosis factor-alpha. Mice expressing the human APOE4 allele (n = 16) demonstrated an increase in mortality following caecal ligation and puncture compared with APOE3TR mice (n = 22; P = 0.039). Administration of the apolipoprotein E mimetic COG1410 was well tolerated and APOE3TR mice treated with peptide (n = 20) demonstrated a significant reduction in mortality compared with vehicle treated animals (n = 20; P = 0.007). A similar effect was also observed in APOE4TR animals, in which treatment with COG1410 was associated with reduced mortality compared with vehicle treatment (n =16 animals/group; P = 0.027). COG1410 was also associated with a reduction in TNFalpha, interleukin-1beta, interleukin-6 and interleukin-12 levels in both APOE3TR and APOE4TR (n = 5 animals/group) assessed at 24 hours. Thus, administration of an apolipoprotein E-mimetic peptide is well tolerated, suppresses inflammatory responses, and improves mortality in a caecal ligation and puncture model of sepsis.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Anaesth Intensive Care

DOI

ISSN

0310-057X

Publication Date

January 2009

Volume

37

Issue

1

Start / End Page

38 / 45

Location

United States

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Treatment Outcome
  • Survival Rate
  • Sepsis
  • Polymorphism, Genetic
  • Mice, Inbred C57BL
  • Mice
  • Ligation
  • Interleukins
  • Granulocyte-Macrophage Colony-Stimulating Factor
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wang, H., Christensen, D. J., Vitek, M. P., Sullivan, P. M., & Laskowitz, D. T. (2009). APOE genotype affects outcome in a murine model of sepsis: implications for a new treatment strategy. Anaesth Intensive Care, 37(1), 38–45. https://doi.org/10.1177/0310057X0903700111
Wang, H., D. J. Christensen, M. P. Vitek, P. M. Sullivan, and D. T. Laskowitz. “APOE genotype affects outcome in a murine model of sepsis: implications for a new treatment strategy.Anaesth Intensive Care 37, no. 1 (January 2009): 38–45. https://doi.org/10.1177/0310057X0903700111.
Wang H, Christensen DJ, Vitek MP, Sullivan PM, Laskowitz DT. APOE genotype affects outcome in a murine model of sepsis: implications for a new treatment strategy. Anaesth Intensive Care. 2009 Jan;37(1):38–45.
Wang, H., et al. “APOE genotype affects outcome in a murine model of sepsis: implications for a new treatment strategy.Anaesth Intensive Care, vol. 37, no. 1, Jan. 2009, pp. 38–45. Pubmed, doi:10.1177/0310057X0903700111.
Wang H, Christensen DJ, Vitek MP, Sullivan PM, Laskowitz DT. APOE genotype affects outcome in a murine model of sepsis: implications for a new treatment strategy. Anaesth Intensive Care. 2009 Jan;37(1):38–45.

Published In

Anaesth Intensive Care

DOI

ISSN

0310-057X

Publication Date

January 2009

Volume

37

Issue

1

Start / End Page

38 / 45

Location

United States

Related Subject Headings

  • Tumor Necrosis Factor-alpha
  • Treatment Outcome
  • Survival Rate
  • Sepsis
  • Polymorphism, Genetic
  • Mice, Inbred C57BL
  • Mice
  • Ligation
  • Interleukins
  • Granulocyte-Macrophage Colony-Stimulating Factor